Ibogaine Treatment for Heroin Addiction
A structured, medically supervised protocol at IBTA in Paulinia, Brazil.
Heroin dependence carries one of the most severe withdrawal syndromes among commonly used substances, and relapse rates after conventional detox remain high. Patients and families researching ibogaine treatment are often doing so after other approaches — inpatient detox, methadone or buprenorphine programs — have not delivered lasting results.
4 days, from admission to clinical discharge
A structured Monday-to-Thursday protocol, with a single supervised overnight stay in a monitored hospital environment.
Admission, exams and screening
Full check-up and first dose
- Welcome, medical history and documentation
- Blood count, liver enzymes (AST/ALT) and ECG
- Clinical evaluation
- First dose (test dose)
Therapeutic integration and high dose
Supervised overnight clinical stay
- Integrative therapy session
- Individual session with the therapeutic team
- Main Reset dose
- Overnight clinical stay with monitoring
Additional dose and integration
Return for therapeutic integration
- Monitoring of clinical progress
- Additional dose of ibogaine
- Integration of the experience
- Multidisciplinary follow-up
Closing and family guidance
Closing meetings
- Closing meeting with patients
- Family guidance meeting
- Guidance on medications and herbal supplements
- Clinical discharge and continuity plan
Care team: psychiatrists, psychologists/psychoanalysts, specialized therapists, 24h hospital nursing staff, and holistic therapists.
Safety
As with other opioids, the transition from heroin use to ibogaine administration requires careful medical management and is always done under supervision. General contraindications are assessed individually during screening.
Exams and evaluation
- — Electrocardiogram (ECG) before administration
- — Complete blood count
- — AST and ALT liver function tests
- — Consent and commitment assessment
- — Psychiatric history and medication review
Required preparation
- — Four days without use of chemical substances (subject to case review)
- — Alcohol abstinence for the period defined during screening
- — Disclosure of all medications and supplements currently in use
- — Arranging a companion and lodging, when applicable
24h ambulance support integrated with a network of more than 40 hospitals and emergency rooms in the Paulínia region.
Contraindications
Severe psychiatric conditions
Schizophrenia, severe uncontrolled psychosis, or a history of psychotic episodes require exclusion or specialized evaluation.
Cardiovascular disease
Heart failure, arrhythmias, a recent heart attack, and other cardiac conditions may rule out treatment; each case is reviewed individually.
Hepatic or renal impairment
Cirrhosis, severe hepatic or renal insufficiency, and dialysis require rigorous medical evaluation.
Patients undergoing cancer treatment
Ongoing oncological treatment requires individual evaluation and may rule out the protocol; each case is reviewed individually.
Does ibogaine have side effects?
Ibogaine's side effects are most noticeable during Reset Day. Their intensity and combination vary from patient to patient.
Individual manifestation: some of these effects may occur, while other patients may not experience any of them. Even without noticeable symptoms, ibogaine's neurological effects continue to take place.
Reset
Effects are most noticeable during the main dose
Variable
Each patient responds individually
Team
Clinical supervision throughout the process
Our facilities
Hospital environment, therapy rooms, and welcoming spaces in Paulínia, São Paulo State, Brazil.
Frequently asked questions
Yes, opioid dependence, including heroin, is one of ibogaine's most studied clinical uses. It is used to address craving and withdrawal symptoms. Suitability is assessed individually during screening.
The standard IBTA protocol is 4 days, including evaluation, assisted administration, and monitoring. Full details on the pillar page: Ibogaine Treatment for Addiction.
The transition is managed under medical supervision, with an individualized assessment of how and when to reduce or stop use before ibogaine administration, prioritizing patient safety.
Talk to our team and find out if treatment is right for you.
Book an evaluation on WhatsApp (+55 19 97107-5864)We'll ask for your name, WhatsApp/phone number, and whether treatment is for you or a family member.